Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Effect of Olmesartan-Based Therapies on Therapeutic Indicators Obtained Through Out-of-Office Blood Pressure

Effect of Olmesartan-Based Therapies on Therapeutic Indicators Obtained Through Out-of-Office... Ambulatory blood pressure (BP) correlates more significantly with hypertension-associated cardiovascular mortality and morbidity than BP obtained in the doctor’s office. Assessing ambulatory BP, either through 24-h monitoring or through protocolized self-measurement at home, is essential in diagnosing and monitoring patients with hypertension. Several ambulatory BP-derived indicators are related with cardiovascular prognosis. These include 24-h, daytime and nighttime BP measurements, BP measurements obtained through home self-measurement, dipping status, morning surge, and BP variability. The objective of this article was to review the effect of olmesartan-based antihypertensive therapy on the main risk variables obtained when assessing ambulatory BP. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cardiology and Therapy Springer Journals

Effect of Olmesartan-Based Therapies on Therapeutic Indicators Obtained Through Out-of-Office Blood Pressure

Gorostidi, Manuel
Cardiology and Therapy , Volume 4 (1) – Jun 13, 2015
Download PDF
12 pages

Loading next page...
 
/lp/springer-journals/effect-of-olmesartan-based-therapies-on-therapeutic-indicators-Sbm2U5PzTR
Publisher
Springer Journals
Copyright
Copyright © 2015 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Cardiology
ISSN
2193-8261
eISSN
2193-6544
DOI
10.1007/s40119-015-0042-2
pmid
26070804
Publisher site
See Article on Publisher Site

Abstract

Ambulatory blood pressure (BP) correlates more significantly with hypertension-associated cardiovascular mortality and morbidity than BP obtained in the doctor’s office. Assessing ambulatory BP, either through 24-h monitoring or through protocolized self-measurement at home, is essential in diagnosing and monitoring patients with hypertension. Several ambulatory BP-derived indicators are related with cardiovascular prognosis. These include 24-h, daytime and nighttime BP measurements, BP measurements obtained through home self-measurement, dipping status, morning surge, and BP variability. The objective of this article was to review the effect of olmesartan-based antihypertensive therapy on the main risk variables obtained when assessing ambulatory BP.

Journal

Cardiology and Therapy – Springer Journals

Published: Jun 13, 2015

References

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
    Mancia, G; Fagard, R; Narkiewicz, K
  • 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)
    James, PA; Oparil, S; Carter, BL
  • Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension
    Weber, MA; Schiffrin, EL; White, WB
  • Achievement of cardiometabolic goals in aware hypertensive patients in Spain: a nationwide population-based study
    Banegas, JR; Graciani, A; de la Cruz-Troca, JJ
  • Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials
    Thomopoulos, C; Parati, G; Zanchetti, A
  • Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association
    Pickering, TG; Miller, NH; Ogedegbe, G; Krakoff, LR; Artinian, NT; Goff, D
  • Home blood pressure measurement has a stronger predictive power for mortality than screening blood pressure measurement: a population-based observation in Ohasama
    Ohkubo, T; Imai, Y; Tsuji, I
  • Cardiovascular prognosis of ‘masked hypertension’ detected by blood pressure self-measurement in elderly treated hypertensive patients
    Bobrie, G; Chatellier, G; Genes, N
  • Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study
    Sega, R; Facchetti, R; Bombelli, M
  • Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study
    Niiranen, TJ; Hänninen, MR; Johansson, J; Reunanen, A; Jula, AM
  • Home blood pressure as a cardiovascular outcome predictor: it’s time to take this method seriously
    Stergiou, GS; Siontis, KC; Ioannidis, JP
  • Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies
    Ward, AM; Takahashi, O; Stevens, R; Heneghan, C
  • Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension
    Verdecchia, P; Porcellati, C; Schillaci, G
  • Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators
    Staessen, JA; Thijs, L; Fagard, R
  • Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study
    Kikuya, M; Ohkubo, T; Asayama, K
  • Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study
    Dolan, E; Stanton, A; Thijs, L
  • IDACO Investigators. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals
    Hansen, TW; Kikuya, M; Thijs, L
  • On behalf of the CARDIORISC Event Investigators. Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study
    De la Sierra, A; Banegas, JR; Segura, J; Gorostidi, M; Ruilope, LM
  • 24-hour efficacy and safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy
    Izzo, JL; Chrysant, SG; Kereiakes, DJ
  • A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide
    Weir, MR; Hsueh, WA; Nesbitt, SD
  • A randomized, double blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study
    Ogihara, T; Saruta, T; Shimada, K; Kuramoto, K
  • Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study
    Punzi, H; Neutel, JM; Kereiakes, DJ
  • Management of hypertension in patients with diabetes using an amlodipine-, olmesartan medoxomil-, and hydrochlorothiazide-based titration regimen
    Ram, CV; Sachson, R; Littlejohn, T
  • Daytime systolic ambulatory blood pressure with a direct switch between candesartan monotherapy and the fixed-dose combination olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-1)
    Zemmrich, C; Lüders, S; Gansz, A
  • Combination therapy in hypertension
    Gorostidi, M; Sierra, A
  • Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study
    Saito, I; Kario, K; Kushiro, T
  • Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks
    Kario, K; Saito, I; Kushiro, T
  • International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) Investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study
    Boggia, J; Li, Y; Thijs, L
  • On behalf of the Spanish Society of Hypertension Ambulatory Blood Monitoring Registry Investigators. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients
    De la Sierra, A; Redon, J; Banegas, JR
  • Influence of circadian time of hypertension treatment on cardiovascular risk: result of the MAPEC study
    Hermida, RC; Ayala, DE; Mojón, A; Fernández, JR
  • A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease
    Rahman, M; Greene, T; Phillips, RA
  • Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension
    Smolensky, MH; Hermida, RC; Portaluppi, F
  • COMPATIBLE Study Group. Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study
    Mori, H; Yamamoto, H; Ukai, H
  • Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone
    Bilo, G; Koch, W; Hoshide, S; Parati, G
  • Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis
    Makani, H; Bangalore, S; Supariwala, A; Romero, J; Argulian, E; Messerli, FH
  • How to best assess blood pressure? The ongoing debate on the clinical value of blood pressure average and variability
    Stergiou, GS; Parati, G
  • Assessment and management of blood-pressure variability
    Parati, G; Ochoa, JE; Lombardi, C; Bilo, G
  • Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study
    Matsui, Y; O’Rourke, MF; Hoshide, S; Ishikawa, J; Shimada, K; Kario, K
  • Enhanced blood pressure-lowering effect of olmesartan in hypertensive patients with chronic kidney disease-associated sympathetic hyperactivity: HONEST Study
    Kario, K; Saito, I; Kushiro, T
  • The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2)
    Parati, G; Bilo, G; Redon, J
  • 24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension
    Lacourcière, Y; Crikelair, N; Glazer, RD; Yen, J; Calhoun, DA